AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Sulphamethoxazole +Trimethoprim in Zambia
7 products registered with ZAMRA — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Trimaprim tablets Tablet Uncoated | 249/001 | Saga Lifesciences Limited | active | 6 Oct 2030 |
| Co-trimoxazole tablets Tablet Uncoated | 144/003 | Missionpharma A/S | active | 14 Aug 2030 |
| Mims Co-trimoxazole suspension Suspension for Oral Use | 155/007 | international drug company ltd | active | 11 Jul 2030 |
| Compound Sulfamethoxazole Tablet Uncoated | 033/005 | North China Pharmaceutical Group International Corporation+ | active | 11 Jul 2030 |
| Novatrim Suspension Suspension for Oral Use | 017/011 | Pharmanova Zambia Limited | active | 14 Oct 2029 |
| Megatrim suspension Suspension for Oral Use | 177/009 | Fourrts (India) Laboratories (Pvt) Limited | active | 24 Jul 2029 |
| Cotrikant tablets Tablet Uncoated | 161/014 | S Kant Healthcare Ltd+ India | active | 7 Jun 2029 |
Sulphamethoxazole +Trimethoprim — ZAMRA Registration Details
ZAMRA (Zambia) has 7 registered products containing Sulphamethoxazole +Trimethoprim, of which 7 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Sulphamethoxazole +Trimethoprim registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.